Pinnacle Associates
DXCM icon

Pinnacle Associates’s DexCom DXCM Stock Holding History

Pinnacle Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$232K Buy
+2,691
New +$224K ﹤0.01% 877
2020
Q3 		– Sell
-2,400
Closed -$243K – 682
2020
Q2 		$243K Buy
+2,400
New +$215K 0.01% 594

Other funds holding DXCM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Pinnacle Associates's DXCM Position: Q3 2026 in Review

Pinnacle Associates opened a new position in DexCom (DXCM) in Q3 2026: 2,691 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #877 among its holdings. This is a return to the name: Pinnacle Associates previously reported a position in DXCM as recently as Q2 2020.

Pinnacle Associates first reported a position in DXCM in Q2 2020 and has held it in 2 quarters since. The position peaked at $243K in Q2 2020. 516 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Pinnacle Associates held 2,691 shares of DexCom worth $232K as of Q3 2026.
  • DexCom was a new Pinnacle Associates position in Q3 2026.
  • DexCom made up ﹤0.01% of Pinnacle Associates's portfolio in Q3 2026, its #877 holding.
  • Pinnacle Associates first reported a position in DexCom in Q2 2020 and has held it in 2 quarters since.
  • Pinnacle Associates's DexCom position peaked at $243K in Q2 2020.
  • 516 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.